Article: Genentech Reports 35 Percent Increase in Non-GAAP Earnings Per Share for Second Quarter; 23 Percent Increase In Product Sales.

Business Editors/Health/Medical Writers

BIOWIRE2K

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--July 9, 2003

Genentech, Inc. (NYSE:DNA) today announced a 35 percent increase in non-GAAP (formerly pro forma) earnings per share for the second quarter of 2003 driven by a 23 percent increase in product sales. Genentech's non-GAAP earnings per share and non-GAAP net income exclude certain charges related to the 1999 Roche redemption of Genentech's stock and certain litigation-related special charges. These charges are itemized in the reconciliation tables below.

For the three months ended June 30, 2003:

-- Non-GAAP earnings per ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!